abstract |
The present invention relates to an AKR1C3 inhibitor of the formula (I) and a process for the preparation thereof for use in the treatment and/or prevention of diseases, and for the production thereof for the treatment and/or prevention of diseases, in particular hemorrhagic disorders and intrauterine The use of drugs for membrane ectopic disease. □ |